Literature DB >> 31449814

Profiling Insulin Oligomeric States by 1H NMR Spectroscopy for Formulation Development of Ultra-Rapid-Acting Insulin.

Bradley T Falk1, Yingkai Liang2, Mark A McCoy3.   

Abstract

Formulations that can increase the dissociation of insulin oligomers into monomers/dimers are important considerations in the development of ultra-rapid-acting insulins with faster onset and shorter duration of actions. Here we present a novel strategy to characterize the oligomeric states of insulin in solution that leverages the ability of nuclear magnetic resonance spectroscopy to assess higher-order structure of proteins in solution. The oligomeric structures and solution behaviors of 2 fast-acting insulins, aspart and lispro, with varying excipient concentrations were studied using 1D and diffusion profiling methods. These methods can provide insight on the structural differences and distributions of the molecular association states in different insulin formulations, which is consistent with other orthogonal biophysical characterization tools. In addition, these methods also highlight their sensitivity to subtle changes in solution behaviors in response to excipient that are difficult to monitor with other tools. This work introduces the utility of 1D and diffusion profiling methods to characterize the oligomeric assembly of fast-acting insulins, suggesting promising applications in compound screening, excipient selection, and formulation development of fast-acting insulins as well as other peptide or protein therapeutics.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  NMR spectroscopy; biopharmaceutical characterization; biosimilar; diffusion; drug-excipient interactions; excipients; insulin; protein formulation; self-association

Mesh:

Substances:

Year:  2019        PMID: 31449814     DOI: 10.1016/j.xphs.2019.07.025

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

Review 1.  New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals.

Authors:  Mark A Jarosinski; Yen-Shan Chen; Nicolás Varas; Balamurugan Dhayalan; Deepak Chatterjee; Michael A Weiss
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

2.  Quality Assurance of Commercial Insulin Formulations: Novel Assay Using Infrared Spectroscopy.

Authors:  Sven Delbeck; H Michael Heise
Journal:  J Diabetes Sci Technol       Date:  2020-04-13

3.  SAXS Reveals the Stabilization Effects of Modified Sugars on Model Proteins.

Authors:  Astra Piccinini; Eva C Lourenço; Osvaldo S Ascenso; Maria Rita Ventura; Heinz Amenitsch; Paolo Moretti; Paolo Mariani; Maria Grazia Ortore; Francesco Spinozzi
Journal:  Life (Basel)       Date:  2022-01-15

Review 4.  Structural principles of insulin formulation and analog design: A century of innovation.

Authors:  Mark A Jarosinski; Balamurugan Dhayalan; Yen-Shan Chen; Deepak Chatterjee; Nicolás Varas; Michael A Weiss
Journal:  Mol Metab       Date:  2021-08-21       Impact factor: 7.422

5.  Aggregation Behavior of Structurally Similar Therapeutic Peptides Investigated by 1H NMR and All-Atom Molecular Dynamics Simulations.

Authors:  Johanna Hjalte; Shakhawath Hossain; Andreas Hugerth; Helen Sjögren; Marie Wahlgren; Per Larsson; Dan Lundberg
Journal:  Mol Pharm       Date:  2022-02-01       Impact factor: 4.939

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.